Peripheral neuropathy decisions — 2003

The veteran's claim for benefits under 38 U.S.C.A. § 1151 was denied because the evidence did not support a finding that his diabetes, peripheral neuropathy, and cardiovascular disorder were caused by VA medical treatment.

The Board denied the veteran's claims for service connection for type II diabetes mellitus and peripheral neuropathy, finding no evidence linking these conditions to his military service.

The Board has remanded the case for additional development due to inadequate evaluation of the veteran's claims, including obtaining treatment records and providing VA examinations.

The Board has remanded the veteran's claims for additional development due to insufficient information on his mental impairment and need for regular A&A.

The Board of Veterans' Appeals (Board) has denied the veteran's claims for increased ratings for PTSD, residuals of a gunshot wound to the left buttock with fracture of the left femur, and sciatic neuropathy. The RO must ensure that all VCAA notice obligations have been satisfied.

The veteran's TDIU claim is being remanded due to the need for additional development, including obtaining VA medical records and adjudicating new service connection claims. The TDIU decision will be reconsidered after these issues are resolved.

The Board found that the veteran's diabetes mellitus is not service-connected and denied his claim for pension benefits due to a combined disability rating of less than 100 percent.

The Board has ordered further development due to the need for additional evidence and clarification. The case is now remanded back to the RO for the requested development.

The veteran's service-connected disabilities do not meet the criteria for special monthly compensation based on the need for regular aid and attendance or being housebound.

The Board dismissed the veteran's appeal regarding his claim for service connection for post-traumatic stress disorder due to a lack of timely filing of a substantive appeal.

The Board has determined that the veteran's peripheral neuropathy is secondary to his service-connected diabetes mellitus, and thus grants the claim for service connection.

The veteran's PTSD is now rated at 100 percent, effective from the date of this decision. His diabetic peripheral neuropathy of both lower extremities remains at 10 percent.

The Board denied the veteran's claims for service connection for peripheral neuropathy and chloracne based on Agent Orange exposure.

The Board has determined that additional evidence is needed to fully and fairly consider the veteran's claim for a compensable evaluation for Hodgkin's disease, including determining whether he has any chronic disorders due to his treatment.

The veteran's service-connected diabetes mellitus is rated at 40 percent, and he has separate ratings of 20 percent for each lower extremity peripheral neuropathy. The erectile dysfunction associated with the diabetes mellitus is also separately rated.

The Board has ordered further development due to pending issues and the court's decision invalidating certain regulations. The case is now remanded for additional examination and consideration.

The case is being remanded for further development of the veteran's claims, including obtaining medical records and conducting examinations to determine the nature and etiology of his peripheral neuropathy and bilateral hearing loss.

The veteran's appeal is being remanded to the RO for scheduling a videoconference hearing before a Veterans Law Judge of the Board.

The Board is remanding the case for further development and consideration, including obtaining new evidence to reopen a previously denied PTSD claim.

The Board granted the veteran's claims for increased ratings for peripheral neuropathy of both lower extremities and erectile dysfunction, with a rating of 20 percent for each condition.